Results 61 to 70 of about 57,339 (296)

Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score‐Matched Study

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Acute kidney injury (AKI) is associated with worse outcomes after percutaneous coronary intervention (PCI). Previous, smaller studies suggested nephroprotective effects of micro‐axial flow pump (mAFP) during PCI. This study aimed to compare renal outcomes of high‐risk PCI with mAFP or intraaortic balloon pump (IABP) support.
Elric Zweck   +10 more
wiley   +1 more source

Mechanical Thrombus Aspiration for a Young STEMI Patient With Plaque Erosion: Time for a Stent‐Free Approach?

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT A 34‐year‐old man with no cardiovascular history presented with anterior ST‐elevation myocardial infarction and a large thrombotic occlusion of the mid left anterior descending artery. Following potent antithrombotic therapy and mechanical thrombus aspiration, angiography revealed vessel patency without residual significant stenosis, allowing ...
Domenico Simone Castiello   +3 more
wiley   +1 more source

Relationship between the TIMI risk score and the angiographic severity of atherosclerosis in patients with acute coronary syndrome without ST elevation: a cross-sectional study

open access: yesRevista Médica de Minas Gerais
Introduction: Cardiovascular diseases, particularly non-ST-segment elevation acute coronary syndrome (NSTE-ACS), are a major concern due to their high morbidity and mortality rates.
Bernardo Buitrago de Andrade   +3 more
doaj   +1 more source

Non-ST segment elevation myocardial infarction in a patient with COVID-19

open access: yesHeart Views, 2020
Coronavirus disease 2019 (COVID-19) is associated with a wide spectrum of cardiovascular (CV) manifestations. Primary cardiac manifestations of COVID-19 disease include acute coronary syndrome (ACS), myocarditis, and arrhythmias. Secondary cardiac involvement is usually due to a systemic inflammatory syndrome and can manifest as acute myocardial injury/
Fahmi Othman   +6 more
openaire   +3 more sources

Treatment of NSTEMI (Non-ST Elevation Myocardial Infarction) [PDF]

open access: yesCurrent Emergency and Hospital Medicine Reports, 2013
Non-ST elevation myocardial infarction (NSTEMI) is a recognized diagnostic entity that has an unacceptable mortality rate when it goes unrecognized. Following diagnosis, initial treatment with analgesics, nitrates and anti-platelet agents forms the initial approach. New anti-platelet agents such as ticagrelor and prasugrel need to be clearly understood.
V. Anantharaman, Swee Han Lim
openaire   +1 more source

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao   +8 more
wiley   +1 more source

Hemodynamic validation of the E/e’ ratio as a measure of left ventricular filling pressure in patients with non-ST elevation myocardial infarction

open access: yes, 2019
The E/e’ ratio has an established role in the assessment of left ventricular filling pressure (LVFP) in stable patients, but its accuracy in acute myocardial ischemia is less well established.
Prasad, Sandhir B.   +10 more
core   +1 more source

Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? [PDF]

open access: yes, 2012
Preliminary data mostly from animal models suggest the sST2/IL-33 pathway may have causal relevance for vascular disease and diabetes and thus point to a potential novel inflammatory link to cardiometabolic disease.
Kevin A. Deans (125089)   +104 more
core   +1 more source

In silico analysis of putative interactions identifies fibroblasts as hubs for cell–cell communication during early regeneration of the zebrafish heart

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background The zebrafish heart regenerates upon injury. During injury response, fibroblasts and endothelial cells accumulate at the site of damage, and cardiomyocyte cell cycle reentry allows cardiac muscle regrowth. It is relevant to understand how the different cell types communicate with each other to coordinate regeneration.
João A. S. Carvalho   +6 more
wiley   +1 more source

Oxidative stress and microcirculatory flow abnormalities in the ventricles during atrial fibrillation

open access: yesFrontiers in Physiology, 2012
Patients with atrial fibrillation (AF) often present with typical angina pectoris and mildly elevated levels of cardiac troponin (non ST-segment elevation myocardial infarction; NSTEMI) during an acute episode of AF.
Andreas eGoette   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy